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Abstract
BRC-Pathema is one of eight National Institute of Allergy and Infectious Diseases 
(NIAID) Bioinformatics Resource Centers. It consists of sophisticated, clade-specific Web 
resources targeting the data and analysis needs of different scientific communities. Among those 
resources are sophisticated bioinformatics software, a comprehensive library of scientific 
literature, and manually curated data. Periodical evaluations by the BRC-Central determine 
Pathema’s level of completeness, accuracy, and consistency. The results of these evaluations 
have revealed the need to develop customized tools for the maintenance of acceptable levels of 
accuracy  and consistency within Pathema’s curated databases of annotated microbial genomes. 
The Annotation Consistency Tool, or ACT, is a customized analysis tool used to investigate and 
assess the consistency  of BRC-Pathema annotated genes against TIGRFAM  equivalog HMMs. 
ACT generates both categorized statistics and dynamic lists of individual HMMs and the 
associated inconsistent genes.
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Background
BRC-Pathema
BRC-Pathema (http://www.pathema.jcvi.org) is the Bioinformatics Resource Center 
(BRC) at the J. Craig Venter Institute (JCVI). BRC-Pathema is one of eight  NIAID-funded BRCs 
designed to support bio-defense and infectious disease research. All eight BRCs are linked via a 
central online portal, the Pathogen Portal (http://www.pathogenportal.org). The BRC-Central 
allows researchers convenient access to all eight BRCs. 
BRC-Pathema aims to provide clade-specific core resources that target the individual data 
and analysis needs of Bacillus-, Clostridium-, Burkholderia- and Entamoeba-centered scientific 
communities. BRC-Pathema’s six target pathogens are Bacillus anthracis, Clostridium 
botulinum, Clostridium perfringens, Burkholderia mallei, Burkholderia pseudomallei, and 
Entamoeba histolytica. Among those resources are sophisticated bioinformatics software, a 
comprehensive library of scientific literature, and manually curated genome annotation data.
All BRC-Pathema gene annotation information is stored over several interrelated 
relational databases: the EGAD database, the COMMON database, and organism-specific SMALL 
GENOMES DATABASES (SGD). 
An SGD is a generic microbial annotation database. Each organism has a corresponding 
SGD containing genomic information including annotation data. A condensed schema 
representing the annotation-relevant tables of an SGD database for a prokaryotic organism can be 
found in the Supplemental Images section. 
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The EGAD database contains Hidden Markov Model (HMM) information and functional 
role identification data. A condensed schema representing the annotation-relevant  tables of EGAD 
can be found in the Supplemental Images section. 
The COMMON database contains “common” information of currently  available genome 
projects, including Gene Ontology (GO) annotation and Genome Property  information. A 
condensed schema representing the annotation-relevant tables of the COMMON database can be 
found in the Supplemental Images section. 
Annotation Pipeline
All functional annotation predictions are made based on one of two main algorithms: 
BLAST Extend Repraze (BER) and HMM. BER-based gene annotations are functional 
assignments based on a detected pairwise homology between the query protein and the results of 
JCVI-modified BLAST searches, also known as BER hits. HMM-based annotations are made 
using the HMMER package, (Eddy, 1998). Two sets of HMMs are used: Sanger’s Pfam HMMs 
(Sonnhammer et al., 1998) and JCVI’s TIGRFAM HMMs (Haft et al., 2001). 
Gene assignments are made based on the best evidence available. Evidence is weighed 
differently depending on the level of specificity of a particular HMM, or the strength of a 
pairwise alignment to an experimentally  characterized BER alignment. Furthermore, TIGRFAM 
HMMs are preferred over Pfam HMMs. The HMMs used at JCVI are categorized by type also 
known as its isology type. Isology types are indicative of the homology or convergence in 
addition to the “degree of confidence” about  function. Isology types include equivalogs, 
hypothetical equivalogs, equivalog domains, Pfam, Pfam equivalog, Pfam equivalog domain, 
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domain, exception, hypothetical equivalog domain, paralog, paralog domain, paralog repeat, 
repeat, signature, subfamily, subfamily domain, and superfamily. 
Equivalog-based HMMs suggest  a higher degree of confidence about function than 
HMMs based on other isology types. Equivalogs refer to a set  of functionally conserved 
homologous proteins in with respect to their last  common ancestor. Homologous regions of 
conserved function are classified as "equivalog domain". In the case that a family  of proteins has 
the phylogenetic characteristics of an equivalog but  its function has not yet been experimentally 
determined, these families are classified as “hypothetical equivalogs”, or “hypothetical equivalog 
domains” when appropriate. 
During the annotation process, each gene is assigned with several “descriptors” which 
include, among others, a protein functional name (common name), gene symbol, enzyme 
commission number (EC number), Gene Ontology (GO) function, process, and component 
identifier(s), and, if and when applicable, an annotation completion process. A common name is 
the name given to the protein encoded by the gene which reflects its biological function. A gene’s 
symbol is an abbreviation of commonly four to five alpha-numeric characters given to identify 
the gene. An EC number is a universal numerical classification of an enzyme reflecting its 
metabolic properties.  A GO identifier is “controlled” numerical identifier reflecting a protein’s 
association to the Gene Ontology’s organizational hierarchy of cellular components, biological 
processes and molecular functions. The annotation status of a gene indicates the state of progress 
of a gene’s annotation. These states include (i) automated annotation by JCVI’s AutoAnnotate 
program, (ii) mapping by MUMmer, and (iii) manual curation.
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Value Addition Statistics
To ensure the credibility  of each BRC, the Pathogen Portal runs a series of tests 
evaluating each BRC’s accuracy, completeness, and consistency by evaluating the annotation 
assigned to BRC-Pathema genes based on hits to TIGRFAM equivalog HMMs. 
To assess the accuracy  of BRC-Pathema, a small set  of preselected TIGRFAM  equivalog 
HMM genes are used to assess the accuracy  of BRC-Pathema annotations. The BRC-Pathema 
proteins that score significantly to these HMMs are inspected and a subjective assessment of the 
correctness of the functional name assignment is made through manual analysis. Based on the 
equivalog isology  of these models, one would expect all BRC-Pathema proteins that score 
significantly to a TIGRFAM  equivalog HMM also share that same function, and thus functional 
names assigned to BRC-Pathema should be the same as those assigned to each TIGRFAM 
model.  The reported accuracy  statistic will be a percentage reflecting the number of “correct” 
function name annotations made.
To evaluate the level of completeness, all TIGRFAM equivalog HMMs are used. Since 
BRC-Pathema proteins that score significantly to a TIGRFAM equivalog are assumed to share 
that same function, the annotation descriptors (i.e. common names and EC numbers) associated 
with each TIGRFAM HMM  should be assigned appropriately to the respective BRC-Pathema 
protein. These descriptors are counted and compared to the total number of expected TIGRFAM 
gene descriptors. Thus, the reported completeness statistic will be a percentage reflecting the 
ratio of the number of actual annotations to the number of expected annotations. The correctness 
of an assignment is not taken into account, only that an assignment has been made.
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Finally, with regard to the consistency, the complete set of BRC-Pathema proteins that 
score significantly to TIGRFAM equivalog HMMs are evaluated based on whether or not each 
set of proteins has been assigned the same gene descriptors as one would expect based on shared 
function. The reported consistency  statistic reflects the likelihood of any two proteins having the 
same annotated text string assigned. 
Once the evaluation of each BRC is completed, the Pathogen Portal publicly reports the 
accuracy, completeness, and consistency statistics of each BRC as seen in Table 1. Each BRC is, 
then, able to assess problematic areas. Based on a recent evaluation, BRC-Pathema's consistency 
was deemed unsatisfactory. 
Table 1. Value Addition Statistics
Accuracy Summary
% Incorrect % Suspicious Overall % Correct
January 2008 0.5% 0.8% 98.7%
July 2007 0.1% 0.7% 99.2%
January 2007 0.3% 1.0% 98.7%
Completeness Summary
Functional Names Genetic Names GO assignment EC #
January 2008 99.1% 87.2% 90.2% 94.5%
July 2007 99.1% 89.3% 90.5% 95.4%
January 2007 100.0% 78.3% 78.2% 55.1%
Consistency Summary
Consistency Measure
January 2008 76.9%
July 2007 80.1%
January 2007 80.2%
Table 1. Report summary on evaluation of BRC-Pathema’s accuracy, completeness, and consistency.
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Due to the framework of the annotation process, ideally, the descriptor assignments given 
to each gene should match the descriptor assignments given to the TIGRFAM equivalog HMM 
to which the gene in question matched the most. The annotation process is such that a gene’s 
descriptors assignment is made based solely on the descriptors of the associated HMM. Thus, 
looking particularly at the common name, gene symbol, and EC number assignments, we should 
expect to see that a gene and the TIGRFAM equivalog HMM used to annotate it should have the 
same common name, gene symbol, and EC number assignments. Any discrepancies would 
contribute to the high inconsistency and high inaccuracy  scores given by the Pathogen during 
evaluation.
 Several major and minor factors could potentially contribute to a discrepancy between 
TIGRFAM equivalog HMM assignments and associated annotated genes. The Pathogen Portal 
performs an exact string comparison. Thus, simple textual differences like an additional white 
space or hyphen will add to the inconsistency count. 
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Introduction
Developed during the summer of 2008, the first iteration of the Annotation Consistency 
Tool (ACT) was designed as a tool used to maintain seemly levels of accuracy and consistency 
by investigating the individual inconsistencies of BRC-Pathema annotated genes against 
TIGRFAM equivalog HMMs. 
ACT iterates through the three aforementioned databases making individual annotation 
assessments of each BRC-Pathema gene and the associated HMM. However, only a subset of 
tables from each aforementioned database and its vast amount of data is actually used by  ACT as 
seen in Figure 1.
 From the EGAD database, ACT accesses the ‘hmm2’ table. The ‘hmm2’ table contains 
HMM annotation data including descriptor data (names, gene symbols, etc.) and cutoffs (the 
Figure 1. Databases, Tables, and Fields Queried by ACT
Figure 1. Only subset of tables and fields of EGAD,  COMMON, and SGD databases 
are queried by ACT.
7
HMM threshold scores) as seen in Figure 2. Because a single protein may have multiple HMM 
hits, it  is necessary to incorporate HMM  threshold scores to determine which HMM  is the best 
hit.
Figure 2: ‘hmm2’ Table Design
Figure 2. Descriptions of fields in ‘hmm2’ table.
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The subset of fields from the ‘hmm2’ table utilized by ACT during analysis includes the 
following:
• hmm2.hmm_acc: The unique alphanumerical identifier of an HMM.
• hmm2.hmm_com_name: The name given to the HMM to suggest its function.
• hmm2.gene_sym:  The name given to identify the gene.
• hmm2.ec_num: The Enzyme Commission (EC) number of a gene. The EC number 
is a universal numerical classification of an enzyme reflecting is metabolizing 
properties.
• hmm2.iso_type: The isology type of an HMM. An isology type dictates the level 
of confidence about function.
From the SGD database(s), the ‘ident’, ‘evidence’, ‘asm_feature’, ‘stan’, and 
‘go_role_link’ tables are utilized by ACT during analysis (Figure 3). The ‘ident’ table 
stores the annotation data associated with a predicted gene model.. The ‘evidence’ table is a 
record of supporting annotation evidence, such as HMM  evidence. The ‘asm_feature’ table 
consists of information relative to predicted gene model nucleotide and translated protein 
sequences, sequence coordinates, etc. The ‘stan’ table holds a record of associated genome 
sequence assembly  information. Finally, the ‘go_role_link’ table holds information linking 
any given feature to the appropriate GO ID(s).
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 The subset of fields from the aforementioned SGD database(s) utilized by ACT during 
analysis includes the following:
• ident.feat_name: The alphanumerical JCVI internal identifier of a protein.
• ident.com_name: The name given to the protein to suggest its function.
• ident.gene_sym: The name given to identify the gene.
Figure 3. ‘ident’, ‘evidence’, ‘asm_feature’, ‘go_role_link’, and ‘stan’ 
Table Designs
Figure 3. Descriptions of fields in ‘ident’, ‘evidence’, ‘asm_feature’, ‘go_role_link’, and 
‘stan’ tables.
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• ident.ec#: The Enzyme Commission (EC) number of a gene. The EC number is a 
universal numerical classification of an enzyme reflecting is metabolizing properties.
• ident.locus: The locus information of gene.
• ident.complete: The status of annotation (manually, automated, MUMMer re-
map, etc.).
• evidence.accession: The unique alphanumerical identifier of the evidence off 
of which the annotation was made.
• evidence.ev_type: The type of evidence (i.e. HMM evidence).
• evidence.curated: The Boolean value reflecting curation.
• asm_feature.feat_type:  The type of genome feature (i.e. RNA, gene, etc.).
• stan.iscurrent: The Boolean value reflecting which sequence assembly  is the 
most current.
• go_role_link.go_id: The GO IDs associated with a gene.
 From the COMMON database, only  the ‘genomes’ table is accessed by ACT during the 
analysis, Figure 4. The genomes table consists, appropriately, of genome information. 
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The three columns from the ‘genomes’ table are utilized by ACT during analysis 
include the following.
• genomes.name: The scientific name of an organism.
• genomes.db: The unique alphanumeric JCVI internal identifier of a database.
• genomes.type: The category indicating the genome type to which a database 
belongs. 
Once the evaluation completes, ACT reports categorized statistics reflecting 
inconsistencies and, as a by-product, the inaccuracies in BRC-Pathema’s annotated genes and 
generates the individual inconsistencies found within BRC-Pathema. In addition, ACT provides 
nomenclature for inconsistent HMMs and/or genes as suggested by the International Union of 
Biochemistry  and Molecular Biology (IUBMB, http://www.iubmb.org/). The first iteration of 
Figure 4. ‘genomes’ Table Design
Figure 4. Descriptions of fields in ‘genomes’ table.
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ACT targets 86 of BRC-Pathema’s microbial genomes.  However, the ultimate goal is to be able 
to run ACT on the entire Comprehensive Microbial Resource (CMR, http://cmr.jcvi.org) 
database which consists of more than 500 completed genomes and several hundred other 
prokaryotic genomes in production. In order to achieve this goal, a complete structural and 
aesthetic overhaul of ACT was inevitable.
Executed via the command-line version or using the Web-based interface, the first 
iteration of ACT takes, on average, approximately one minute to process a single prokaryotic 
genome. A linear scale-up in runtime is observed. Consequently, analyzing the 86 original target 
genomes in BRC-Pathema, ACT’s average runtime is two hours. On an individual level, a minute 
is an acceptable time. However, if applied to CMR’s 400 plus completed genomes, ACT will 
accordingly  take more than five times longer, and that  is simply unacceptable as most Web 
browsers will time out before the process ever completes. Thus, the foremost objective for ACT 
development was to improve its runtime in order to be able to analyze a larger data set in a 
reasonable amount of time. This required a complete redesign of ACT algorithm and careful 
SQL query statement optimizations.
The second objective was to enhance ACT’s Web-based interface for improved usability. 
The first iteration of ACT’s Web-based interface generates primitive HTML displays which, 
more often than not, clutter the Web page making it difficult for users to sort through the analysis 
results. To address this issue, technologies like Cascading Style Sheets (CSS), JavaScript, 
Asynchronous JavaScript and XML (AJAX), and jQuery were utilized to sensibly  reduce the 
overwhelming amount of information returned by ACT and generate a more fluid and dynamic 
interface.
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Materials and Methods
Time Study
 The first iteration of ACT had an average runtime of one (1) minute per genome. After 
SQL optimization, the average runtime was decreased to forty-one (41) seconds per genome. 
After the restructuring of the algorithm, the runtime was cut significantly  to an average of two 
(2) seconds per genome. To achieve this success, several concerns were identified and addressed 
as mentioned in subsequent sections.
Algorithm Analysis
 To address the unwieldy runtime of the first  iteration of ACT, a closer look was taken at 
the original algorithm as seen in Figure 5.
Figure 5. Original Algorithm of ACT
Obtain all Isology types;
Obtain all HMMs;
For all HMMs{
 Obtain HMM’s common name, gene symbol, and EC number;
 For all organisms{
        Obtain all genes;
        For all genes{
               Obtain gene’s common name, gene symbol, and EC number;
               Compare common name pair;
                      - Increment inconsistency count if inconsistent;
               Compare gene symbol pair;
                      - Increment inconsistency count if inconsistent;
               Compare EC number pair;
                      - Increment inconsistency count if inconsistent;
        }
 }
}
Report results;
Figure 5. The original algorithm of ACT performed thousands of unnecessary iterations to irrelevant organisms 
and genes.
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 In the original algorithm, ACT extracts and stores an array of all evidences of the isology 
types specified by the user. Equipped with an array  of all the TIGRFAM HMMs of interest, ACT 
iterates through each HMM  and each organism specified by the user and extracts all the genes 
annotated with the current HMM. As these associated genes are extracted, a string comparison of 
the stringency specified by the user is performed on the three key descriptors of the current 
HMM against those of the current gene. Upon careful investigation, several problems were 
identified within the algorithm. 
First, ACT obtained a list of all HMMs. This list included HMMs not used to annotate the 
user-specified list of organisms, but only the HMMs used to annotate the user-specified list of 
organism should be obtained. These additional HMMs lead to another more pressing issue.
The second issue was found in the iteration through the list  of HMMs. For each HMM, 
iteration through all the organisms is performed. It  is not always the case that each HMM is used 
to annotate a gene (or multiple genes) in each of the user-specified organisms. So, it is 
unnecessary  to iterate through all the organisms. This iteration through all the organisms 
becomes not only unnecessary but inefficient when paired with an HMM  that was not used to 
annotate any of the genomes at all. 
The third concern was with the iteration of all genes. It is not  the case that the HMM will 
annotate all genes in a single organism, and it is definitely not the case that any one HMM will 
annotate all genes in all organisms specified by the user. In fact, only a handful of genes in any 
given genome, at most, are annotated by a single HMM. In most cases, a single HMM  annotates 
only a single gene from any one microbial genome because as a single-celled, haploid genome, 
the organism only needs a single copy  of the gene to function and survive. Thus, for any one 
15
HMM, the iteration through thousands of genes for any one organism is not only unnecessary  but 
inefficient and time-consuming. In the case of unused HMMs, these iterations over thousands of 
genes per genome are wasted entirely.
These issues have contributed to the lengthy average runtime of one minute per genome. 
In the original algorithm, each HMM, used or unused, calls for an iteration through the user-
specified list  of genomes and every annotated gene within those genomes. Thus, for any given, 
run of ACT, thousands of iterations, at the very least, were pointlessly performed.
In the second iteration of ACT, these three major issues in the algorithm were addressed, 
and new algorithm was formulated, Figure 6.
Figure 6. Improved Algorithm of ACT
Obtain all Genomes{
 Obtain all Genes;
 For all genes{
  Obtain all used HMMs and Genome-Gene to which it is associated;
 }
}
For all used HMMs{
Obtain HMM’s common name, gene symbol, and EC number;
Obtain Genome-Genes associated{
Obtain gene’s common name, gene symbol, and EC number;
Compare common name pair;
- Increment inconsistency count if inconsistent;
Compare gene symbol pair;
- Increment inconsistency count if inconsistent;
Compare EC number pair;
- Increment inconsistency count if inconsistent;
}
}
Report results;
Figure 6. In the improved algorithm, ACT only iterates through the relevant organisms and genes,  eliminating the 
thousands of wasted iterations and thereby significantly reducing ACT’s average runtime.
 In the revised algorithm, the first step is to iterate through all the user-specified genomes 
and their respective genes. While iterating through the genes of a genome, the HMMs used to 
annotate each gene are recorded. At the end of the iteration, ACT has obtained a list  of all the 
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used HMMs, meaning only the HMMs used to annotate the genes of the user-specified genomes. 
This eliminates the first concern of iterating through unnecessary HMMs in the original 
algorithm.
 ACT then iterates through the list of only the used HMMs. For each HMM, the list of 
associated genomes and genes are revisited and iterated through. As these associated genes are 
extracted, a string comparison of the stringency specified by the user is performed on the three 
key descriptors of the current HMM  and the current gene. This eliminates the second and third 
concern that unnecessary iterations through genomes and, in the other case, genes are being 
performed. 
SQL Query Optimization
 During a given ACT run, ACT executes several types of SQL commands, Figure 7. To 
ensure the effectiveness of the SQL commands, each SQL command was individually evaluated.
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Figure 7. Original SQL Queries of ACT
SELECT  name, db 
FROM  common..genomes
WHERE  (type like “BRC-microbial”) AND
(name like “Bacillus%” or name like “Burkholderia%” or name like “Clostridium%”)
SELECT  name 
FROM  common..genomes 
WHERE  db like [DB_NAME]
SELECT  hmm_acc, hmm_com_name, gene_sym, ec_num, iso_type 
FROM  egad..hmm2 
WHERE  iso_type LIKE [ISO_TYPE] AND 
hmm_acc LIKE “TIGR%”
SELECT  DISTINCT (i.feat_name), i.com_name, i.gene_sym, i.ec#, i.locus, i.complete, 
e.accession 
FROM  [DB_NAME]_name..ident i, [DB_NAME]_name evidence e, [DB_NAME]_..asm_feature a, 
DB_NAME]_..stan s 
WHERE  (i.feat_name = e.feat_name) AND 
(s.asmbl_id=a.asmbl_id) AND 
(s.iscurrent = 1) AND 
(a.feat_type LIKE ‘ORF’) and 
(e.accession LIKE [HMM_ID]) and 
(e.ev_type LIKE [EV_TYPE]) AND 
(e.curated = 1)
SELECT  COUNT (go_id) 
FROM  [DB_NAME]..go_role_link 
WHERE  feat_name LIKE [FEATURE_ID]
Figure 7. Several of queries executed by ACT were in need of optimization to ensure a more efficient overall 
average runtime. 
 In the first iteration of ACT, five different SQL commands are executed. The first 
command extracts all the organisms “of interest”. The second command extracts the scientific 
name of a specified database. The third command extracts all the HMMs of a specified isology 
and each HMM’s associated information. The fourth command extracts all features and their 
associated information in a specified database of specified HMM  and evidence type. The fifth 
command returns the number of GO IDs assigned to specified feature in specified database.
 A seemingly minor alteration was made to several ‘where’ clauses of specific queries. 
This minor alteration was simply replacing “LIKE” with an “=”. This simple change reduced the 
average runtime of one (1) minute per genomes to fourty-one (41) seconds per genome, Figure 8.
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 While a significant impact was made with such a simple change, major changes in the 
SQL queries were made to accommodate the new algorithm, Figure 8.
Figure 8. Optimized SQL Queries of ACT
SELECT  name, db 
FROM  common..genomes 
WHERE  type IN (‘microbial’, ‘BRC-microbial’, ‘nt-microbial’) AND 
stage IN (‘pre-annotation’, ‘annotation’, ‘post-annotation’, ‘published’)
SELECT  name 
FROM  common..genomes 
WHERE  db = [DB_NAME]
SELECT  type 
FROM  common..genomes 
WHERE db = [DB_NAME]
SELECT  hmm_acc, hmm_com_name, gene_sym, ec_num, iso_type 
FROM  egad..hmm2 
WHERE  iso_type IN (‘equivalog’, ‘hypoth_equivalog’, ‘equivalog_domain’) AND
hmm_acc LIKE “TIGR%”
SELECT  DISTINCT (i.feat_name), i.com_name, i.gene_sym, i.ec#, i.locus, i.complete, 
e.accession, e.ev_type 
FROM  [DB_NAME]..ident i, [DB_NAME]..evidence e, [DB_NAME]..asm_feature a, [DB_NAME]..stan 
s, 
WHERE  (i.feat_name = e.feat_name) AND 
(s.asmbl_id = a.asmbl_id) AND 
(i.feat_name = a.feat_name) AND
(s.iscurrent = 1) AND 
(a.feat_type = ‘ORF’) AND 
(e.accession LIKE “TIGR%”) AND 
(e.ev_type = ‘HMM2’) AND 
(e.curated = 1)
SELECT  go_id 
FROM  [DB_NAME]..go_role_link 
WHERE  feat_name = [FEATURE_ID]
SELECT  COUNT (go_id) 
FROM  [DB_NAME]..go_role_link 
WHERE  feat_name = [FEATURE_ID]
Figure 8.  Several queries were optimized with a simple substitution of “LIKE” with an “=”. Other queries were 
reformatted to accommodate the improved algorithm of ACT.
The first command extracts all the organisms “of interest”. The second command extracts 
the scientific name of a specified database. The third command extracts the genome type of the 
specified database. The fourth command extracts all the HMMs of a specified isology and each 
HMM’s associated information. The fifth command extracts all features and their associated 
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information. The sixth command returns the GO IDs associated assigned to the specified feature 
in the specified database. The seventh command extracts the number of GO IDs assigned to the 
specified feature in the specified database.
Web Interface Development
The Web interface of the first iteration of ACT was developed solely with HTML (Figure 
9). Due to the amount of information returned by  ACT, the Web page was easily cluttered with 
tables upon tables of information making it overwhelming for the user to have to sort through. 
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In an attempt to address these issues, the Web interface of the current  iteration of ACT, as 
seen in Figure 10, utilizes several technologies including CSS, JavaScript, and AJAX to reduce 
the overwhelming amount of information into a more organized display. The application of 
jQuery has introduced, with great simplicity and ease, the use of JavaSript and AJAX to ACT as 
well as the ability to manipulate existing CSS.
Figure 9. Original ACT Web-Based Interface
Figure 9. The ACT’s original Web interface lacked both style and ease of use.
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In the start-up  page, jQuery was used to filter the list of genomes in the select list by 
genome type and annotation stage, Figure 11. There several options to filter the list  of genomes 
from which users select. The genome types include microbial genomes, BRC-microbial 
genomes, and NT-microbial genomes. Genomes of type BRC-microbial are genomes sequenced 
on the BRC contract. Genomes of type NT-microbial are genomes sequenced from an external 
sequencing center. Genomes of type microbial are genomes sequenced and annotated internally 
at JCVI. For each of the genome types, the user simply  selects the annotation stage(s) (pre-
annotation, annotation, post-annotation, published, and completed) of interest. 
Figure 10. Improved ACT Web-Based Interface
Figure 10. The use of CSS created a more readable and more organized interface.
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For the ACT Results page, jQuery is used to dynamically display the HMM results based 
on the category selected by the user. Each of the links in the Breakdown Statistics section toggles 
the inconsistency information tables in the Inconsistency section as seen in Figure 12.
Figure 11. Genome List Filtering
Figure 11. The use of jQuery enables the filtering of the genome list by genome type and annotation stage. The 
selection area is populated with genomes based on the filters selected.
Figure 12. Interactive ACT Results Page
Figure 12. The use of jQuery enables the toggling of categorized inconsistency results.
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When first  loaded, the Inconsistency section is empty as no links have been selected. 
However, when the user selects a link, the appropriate inconsistency information tables populate 
the Inconsistency section of the ACT Results page.
Inconsistency information tables can also be toggled as seen in Figure 13. Depending on 
the assessment status of the evidence, the evidence table is either display  collapsed or expanded. 
If assessment for a specified evidence has been completed, the information table is displayed in 
the collapsed view. If assessment for a specified evidence has not yet been completed, the 
information table is displayed in the expanded view. 
By clicking the toggle icon, , the inconsistent gene information is collapsed, leaving 
only the evidence information to be visible. By clicking the toggle icon, , the hidden the 
inconsistent gene information is fully displayed.
With the addition of these technologies, ACT’s Web-based interface had improved from 
the very superficial aesthetic upgrades to the structural upgrades for improved dynamics.
Figure 13. Interactive Individual Inconsistency Information Table View
“Collapsed” Display
“Expanded” Display
Figure 13. The use of jQuery enables the toggling of individual inconsistency results.
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Genome Data Set Expansion
The first iteration of ACT targeted the 86 of BRC-Pathema’s microbial genomes. 
However, the goal of ACT was, ultimately, to analyze the Comprehensive Microbial Resource 
(CMR) database. The current iteration of ACT now includes the more than 500 completed 
genomes and several hundred other prokaryotic genomes in production in the CMR database. 
As of 16 April 2009, there are 881 genomes within the scope of ACT. These include 
genomes of various types and in different stages of the annotation pipeline as seen in Table 2. 
The “types” of genomes include microbial genomes, BRC-microbial genomes, and NT-microbial 
genomes. The “stages” of annotation include pre-annotation, annotation, post-annotation, 
published, and completed genomes.
Table 2. Genome Categorization
Annotation Stage
Pre-
Annotation Annotation
Post-
Annotation Published Completed ACT Total Total
Gen
ome 
Typ
e
Microbial 24 153 38 53 18 286 709
BRC-Microbial 1 4 0 14 92 111 113
NT-Microbial 10 48 0 425 1 484 816
ACT Total 35 205 38 492 111 881 1638
Total 60 307 79 510 112 1068
*As of 16 April, 2009
Table 2. There are a total of 881 genomes within the scope of ACT with genomes types of ‘microbial’, ‘BRC-
microbial’,  and ‘nt-microbial’ and annotations stages of pre-annotation, annotation, post-annotation, published, and 
completed. The “Total” row and column refer to the total number of genomes within the corresponding category 
regardless of the scope of ACT.
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Results
ACT Structure
ACT consists of several core interdependent Perl modules: ACT.pm, CompareACT.pm, 
QueryACT.pm, ParseACT.pm, PrintACT.pm, and CommentACT.pm. The relationships 
among the modules are depicted in Figure 14.
Each module was designed to perform a particular set of functions. These functions are 
described below:
• ACT. ACT.pm is the central, core analysis module. ACT.pm was designed to prepare 
and execute the core analysis. There is only one subroutine defined in ACT.pm: 
analyze(). 
Figure 14. ACT Module Relationship Diagram
Figure 14. ACT is comprised of several core, interdependent functional. .modules.
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o analyze(): This is the sole method that is called by either the command-line 
program or the CGI to execute the analysis. Given a query object, the reference to 
the one-dimensional array  of organisms, the reference to the one-dimensional 
array  of evidence types, the stringency level on which to compare common 
names, the stringency level on which to compare gene symbols, and the 
stringency level on which to compare EC numbers, the method will perform the 
consistency analysis and return, as a result, a reference to a four-dimensional hash 
(quadruple-key hash) of statistics by  clade and organism,  a reference to a two-
dimensional hash (double-key hash) of overall statistics, a reference to a one-
dimensional hash (single-key hash) of one-dimensional arrays of inconsistent 
evidence and genes information, a reference to a one-dimensional hash (single-
key hash) of evidence objects, a reference to a one-dimensional hash (single-key 
hash) of gene objects, and a reference to a one-dimensional hash (single-key hash) 
of genome objects.
o init_all_genomes(): Given a reference to a one-dimensional array  of 
organisms, a reference to a one-dimensional array  of evidence, and a query  object, 
this method initializes genome objects for each organism. Genome initialization 
includes the initialization of each organisms genes which is performed by the 
init_all_genes() method as well as records all information on evidence 
and its associated genes. This method returns a reference to a one-dimensional 
hash (single-key hash) of genome objects, a reference to a one-dimensional hash 
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(single-key hash) linking evidence to its associated genes, and a reference to a 
one-dimensional hash (single-key hash) of gene objects.
o init_all_genes(): Given an organism’s database ID and a query object, 
this method initializes gene objects for each gene within the specified genome as 
well as records information on the evidence used to annotate the genes. This 
method returns a reference to a one-dimensional hash (single-key hash) of gene 
objects and a reference to a one-dimensional hash (single-key hash) linking 
evidence to its associated genes.
o init_all_evidence(): Given a reference to a two-dimensional hash 
(double-key hash) of evidence information and a query object, this method 
initializes an evidence object for each evidence and returns a one-dimension hash 
(single-key hash) of evidence objects.
o unique_array(): Given a one-dimensional array, this method removes its 
redundant elements. This method then returns a reference to the one-dimensional 
array of unique elements.
o get_percent(): Given a numerator, a denominator, a numerical figure 
reflecting the desired place value, this method determines and returns the 
percentage value of the numerator and denominator.
• CompareACT. CompareACT.pm is a string comparing module. CompareACT.pm was 
designed to perform string comparisons of varying stringency  levels. The following are 
methods defined within the CompareACT.pm module:
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o check(): Given two strings and a stringency  level (string), this method will 
perform a comparison of the two strings using the specified level of stringency. 
The options for stringency level are: strict, lenient, case, and char. 
 strict - Case sensitive and complete match.
 lenient - Case insensitive and partial match.
 case - Case sensitive, but partial match.
 char - Case insensitive, but complete match.
o strict(): Given two strings, this method will perform a case-sensitive and 
complete string comparison. Only exact matches will return true. 
 Example: “GenOMes” matches only “GenOMEs”. It will not match 
“genomes” or “metaGenOMes”.
o lenient(): Given two strings, this method will perform a case-insensitive and 
partial string comparison.
 Example: “GenOMes” matches “GenOMes”, “genomes”, and 
“metaGenOMes”.
o case(): Given two strings, this method will perform a case-sensitive and partial 
string comparison.
 Example: “GenOMes” matches “GenOMes” and “metaGenOMes”. It 
will not match “genomes”.
o char(): Given two strings, this method will perform a case-insensitive and 
complete string comparison.
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 Example: “GenOMes” matches “GenOMes” and “genomes”. It will not 
match “metaGenOMes”.
• QueryACT. QueryACT.pm is a database querying module. QueryACT.pm was 
implemented and designed to be the database interface (DBI) for ACT. Essentially all 
queries made by ACT are performed by  executing a method in the QueryACT.pm 
module. The following are methods defined within the QueryACT.pm module:
o get_all_db(): This method extracts all genomes (scientific name, database 
name, genome type, and annotation stage) with a genome type of BRC-microbial, 
nt-microbial, and microbial and in pre-annotation, annotation, post-annotation, 
published, or completed annotation stage.
o get_db_org(): Given the database name, this method returns the scientific 
name (field: common..genomes.name).
o get_db_type(): Given the database name, this method returns the genome 
type (field: common..genomes.type).
o get_all_hmm(): This method extracts all TIGRFAM HMMs with an isology 
type of equivalog, hypothetical equivalog, and equivalog domain.
o get_feat(): Given the database name, this method extracts the specified 
organism’s curated genes annotated by  a TIGRFAM HMM and has a feature type 
of ‘ORF’.
o get_go(): Given the database name and the gene (feat_name), this method 
returns the associated GO IDs.
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o get_go_count(): Given the database name and the gene (feat_name), this 
method returne the number of associated GO IDs.
• ParseACT. ParseACT.pm is a file-parsing module. ParseACT.pm was designed to 
parse the contents of a file into data structures. The following are methods defined within 
the ParseACT.pm module:
o ec_to_hash(): Given the file name of the IUBMB  database flat file, this 
method parses the file into a one dimensional hash (single-key hash) with the EC 
number as the 'key' and the associated common name as the 'value'.
o file_to_array1(): Given a file name, this method parses the file into a one 
dimensional array  with each line of the file saved as an element in a one-
dimensional array.
o file_to_array2(): Given the file name of a tab-delimited file, this method 
parses the file into a two dimensional array.
o file_to_hash1(): Given the file name of a tab-delimited or '='-delimited 
file, this method parses the file into a one dimensional hash (single-key hash) in 
which data to the left of the [tab]/'=' is the 'key' and data to the right of the 
[tab]/'=' is the 'value'.
• PrintACT. PrintACT.pm is a printing module used solely by the command-line version 
of ACT. PrintACT.pm was designed to print a data structure out to standard out or to a 
text file in a meaningful way. The following are methods defined within the 
PrintACT.pm module:
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o array1_to_stdout(): Given a reference to a one-dimensional array, this 
method prints a one-dimensional array to standard out.
o hash1_to_stdout(): Given a reference to a one-dimensional hash, this 
method prints a one-dimensional hash (single-key hash) to standard out.
o hash2_to_stdout(): Given a reference to a two-dimensional hash, this 
method prints a two-dimensional hash (double-key hash) to standard out.
o hash3_to_stdout(): Given a reference to a three-dimensional hash, this 
method prints a three-dimensional hash (triple-key hash) to standard out.
o string_to_text(): Given a string and a file name, this method prints a 
string out to a text file with the specified file name.
o array1_to_text(): Given a reference to a one-dimensional array and a file 
name, this method prints a one-dimensional array out to a text file with the 
specified file name.
o array2_to_text(): Given a reference to a two-dimensional array and a file 
name, this method prints a two-dimensional array as a tab-delimited table out to a 
text file with the specified file name.
o hash2_to_text(): Given a reference to a two-dimensional hash, a reference 
to a one-dimensional array of column names, a file name, and the “first  column 
name” (Cell (0,0)), this method prints a two-dimensional hash (double-key hash) 
as a tab-delimited table out to a text file with the specified file name.
• CommentACT. CommentACT.pm controls access to and from the flat file containing 
evidence comments. This module is only used by Web-based ACT.
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o to_hash(): Given the file name of the tab-delimited comments flat file, this 
method extracts the evidence ID, the commenters’ user names, the timestamps of 
each comment, and the comments and saves each comment into a three-
dimensional hash (triple-key  hash) with the first  key as the evidence ID, the 
second key as the user name, the third key as the timestamp, and the comment as 
the triple keyed value.
o to_file(): Given the file name of the comments flat file, the evidence ID, the 
commentor’s user name, the timestamp of the comment, and the comment, this 
method appends the new comment to the comments flat file.
ACT Objects
 As previously mentioned, ACT accesses three databases to obtain information on 
genomes, its associated genes, and linked evidence, which, in this case, are HMMs as seen in 
Figure 15. To hold the associated information, ACT generates three object types: a Genome 
object, a Gene object, and an Evidence object. A Genome object holds the genome’s scientific 
name, database name, clade, genome type, and an array of gene objects. A Gene object hold the 
gene’s feature ID, common name, gene symbol, EC number, genome, locus, complete, accession, 
and evidence. An Evidence object holds the accession number, common name, gene symbol, EC 
number, and isology type of the specified evidence. 
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Figure 15. Object Oriented Design
Figure 15.   ACT accesses information on genomes, its genes,  and the linked HMM evidence. ACT generates an 
object type for each of the main identities: a Genome object, a Gene object, and an Evidence object.
ACT Overview
As with the first iteration of ACT, the current iteration of ACT is also available in one of 
two functionally equivalent forms: a command line executable or a Web-based application. Both 
command-line ACT and Web ACT, require several parameters which include a list of organisms 
or database names, the evidence type, and the stringency levels by which to compare common 
names, gene symbols, and EC numbers. 
If the a gene’s associated common name, gene symbol, or EC number string does not 
match the current HMM’s common name, gene symbol, or EC number, then the current gene 
will be flagged as inconsistent and the inconsistency counts will be incremented accordingly. 
ACT tallies these inconsistencies into several statistical categories which are reported in both the 
Overall Statistics and Breakdown Statistics for a given ACT run: 
• Overall inconsistencies: Total number of genes with at least one inconsistent descriptor.
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• Inconsistencies by data type:
o Common name inconsistencies: Number of genes with an inconsistent common 
name.
o Gene symbol inconsistencies: Number of genes with an inconsistent gene symbol.
o EC number inconsistencies: Number of genes with an inconsistent EC number. 
• Inconsistencies by isology
o Equivalog inconsistencies: Number of equivalog-based genes with at least one 
inconsistent descriptor.
o Equivalog domain inconsistencies: Number of equivalog domain-based genes 
with at least one inconsistent descriptor.
o Hypothetical equivalog inconsistencies: Number of hypothetical equivalog-based 
genes with at least one inconsistent descriptor.
• Inconsistencies by completion method
o Automated inconsistencies: Number of genes annotated by AutoAnnotate with at 
least one inconsistent descriptor.
o Mapping inconsistencies: Number of genes annotated by MUMmer with at  least 
one inconsistent descriptor.
o Manual inconsistencies: Number of genes manually annotated with at least one 
inconsistent descriptor.
Once the analysis completes, these tallies are organized to report an overall statistic in 
addition to statistics by  clade as well as by organism. Although both the command-line and Web-
based versions of ACT are functionally equivalent, their interfaces are inevitably different. The 
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means of passing the required analysis parameters and the display of results are discussed in the 
following sections.
Command-line ACT
 In the command-line version of ACT, the user dictates the parameters of the analysis by 
designating specific files in the convocation of the program as seen in Figure 16.
Figure 16. Command-line Invocation
perl commandACT.pl [org.txt] [ev_type.txt] [cn_level] [gs_level] [ec_level]
Figure 16.  The command-line invocation of ACT requires the specification of five parameters: two text files and 
three strings (“strict”, “lenient”, “char”, or “case”).
The first argument, [org.txt], is a text file containing a list  of organism database IDs of 
interest. Each line of the text file consists only  of a single database ID. The second argument, 
[ev_type.txt], is a text file containing the evidence types of interest. It is important to note that 
ACT only  evaluates evidence types of type “HMM2”. More specifically, ACT retrieves 
TIGRFAM HMMs based on the isology type of “equivalog” which include equivalog HMMs, 
equivalog domain HMMs, and hypothetical equivalog HMMs. The third, fourth, and fifth 
parameters ([cn_level] [gs_level] [ec_level]) specify stringency levels on which to 
compare common names, gene symbols, and EC numbers respectively. There are currently four 
types of stringency levels from which the user can choose: strict, lenient, case, and 
char. The “strict” option performs a case-sensitive and complete string comparison. The 
“lenient” option performs a case-insensitive and partial string comparison. The “case” 
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option performs a case-sensitive but partial string comparison. The “char” option performs a 
case-insensitive but complete string comparison. 
To run default parameters, the user simply specifies “default” for the desired 
argument(s). If “default” is specified for the first argument, [org.txt], command-line ACT 
will parse the file DEFAULT_ORGANISMS.txt found in the /data/ directory of ACT directory. 
This file contains the 881 organisms within the scope of ACT. If “default” is specified for the 
second argument , [ev_type.txt] , command-l ine ACT wil l parse the f i le 
DEFAULT_EVIDENCE.txt found in the /data/ directory  of ACT directory. This file currently 
contains only “HMM2” as ACT is only capable of analyze evidence of type “HMM2”. If 
“default” is specified for the third argument, [cn_level], command-line ACT will run a 
strict stringency level comparison of common names. If “default” is specified for the fourth 
argument, [gs_level], command-line ACT will run a lenient stringency level comparison of 
gene symbols. If “default” is specified for the fourth argument, [ec_level], command-line 
ACT will run a strict stringency level comparison of EC numbers.
When the analysis is completed, three text files are generated by  the command-line 
version of ACT: act_overall.txt, act_breakdown.txt, and act_results.txt. 
The act_overall.txt file is a tab-delimited table of the overall inconsistency  statistics 
categorized into the aforementioned categories as seen in Figure 17. 
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 The act_breakdown.txt file consists of a tab-delimited table of statistical 
information on the aforementioned categories are broken down by clade and by organism as seen 
in Figure 18.
The act_results.txt file consists of the inconsistent evidence and genes 
information as seen in Figure 19. For each evidence, its accession number, common name, gene 
Figure 17. Command-line Results – Overall Statistics
 
Figure 17.   The act_overall.txt file consists of a tab-delimited table of the overall 
inconsistency statistics.
Figure 18. Command-line Results – Breakdown Statistics
Figure 18. The act_breakdown.txt file consists of a tab-delimited table of the inconsistency 
statistics broken down by clade and by organism.
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symbol, and EC number are displayed. Immediately following are the associated genes deemed 
to be inconsistent with the common name, gene symbol, and/or EC number assignments of the 
current evidence. For each gene, its feature ID, organism database ID, locus, common name, 
gene symbol, and EC number are displayed. When an assignment matches the evidence, an 
asterisk is inserted into the appropriate field. Finally, if applicable, nomenclature suggestions 
from the IUBMB are listed.
Figure 19. Command-line Results – Inconsistent Evidence
Figure 19.  The act_results.txt file consists of a tab-delimited list of inconsistent evidence 
and the associated genes.
Web ACT
 In the Web-based version of ACT, the user dictates the parameters of the analysis by 
filling in the Web form as seen in Figure 20. The Genome Selection section of form allows the 
user to filter the genomes to be listed in the Web select area by selecting or deselecting HTML 
checkboxes for the appropriate filter.  The user can then select the genome(s) of interest from the 
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Web select area. Selected genomes will be highlighted. The Analysis Options section of the form 
allows the user to select evidence type to analyze as well as the stringency levels on which to 
compare common names, gene symbols, and EC numbers. It is important to note that ACT only 
evaluates evidence types of type “HMM2”. More specifically, ACT retrieves TIGRFAM HMMs 
based on the isology  type of “equivalog” which include equivalog HMMs, equivalog domain 
HMMs, and hypothetical equivalog HMMs. As with the command-line version of ACT, there are 
currently four types of stringency levels from which the user can choose: strict, lenient, case, and 
char. The “strict” option performs a case-sensitive and complete string comparison. The 
“lenient” option performs a case-insensitive and partial string comparison. The “case” 
option performs a case-sensitive but partial string comparison. The “char” option performs a 
case-insensitive but complete string comparison.
In the Analysis Options section, the parameters have already  been set to default. The 
Evidence Type defaults to “HMM2” as ACT can only  analyze evidence of type “HMM2”. The 
Common Name Stringency Level is set to “strict”. The Gene Symbol Stringency Level is set 
to “lenient”. The EC Number Stringency Level is set to “strict”. 
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Figure 20. Web-based Start-up Page
 
Figure 20. On the Start-up Page, the user specifies the genomes and evidence types to be analyzed and the 
stringency levels on which to compare common names, gene symbols, and EC numbers.
When the analysis is completed, Web-based ACT generates the Overall Statistics and 
Breakdown Statistics sections of results as seen in Figure 21. The Overall Statistics section 
consists of the overall statistics information. The Breakdown Statistics section consists of 
statistics information broken down by clade and by organism. 
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The Inconsistency section consists of the inconsistent evidence and genes information is 
populated only when a chosen statistic has been toggled. Each number reported in the 
Breakdown Statistics section toggles the specific HMMs responsible for the chosen statistics as 
seen in Figure 22.
Figure 21. Web-based Results – Overall & Breakdown Statistics
Figure 21. The results page of Web-based ACT, on default, displays the overall 
statistics and the breakdown statistics for any given ACT run.
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 For each evidence table, several pieces of information are returned as seen in Figure 23. 
This includes evidence information such as evidence accession number, common name, gene 
symbol, and EC number. For each evidence, all associated inconsistent genes are listed along 
with their information (feature name, locus ID, common name, gene symbol, and EC number). 
When an assignment matches the evidence, an asterisk is inserted into the appropriate field. 
Finally, if applicable, nomenclature suggestions from the IUBMB are listed.
Figure 22. Web-based Results – Inconsistent Evidence
Figure 22. The Inconsistency section is populated by selecting a link in the 
Breakdown statistics table.
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Figure 23. Individual Inconsistent Evidence
Figure 23. Each inconsistent information table displays the common names, gene symbols, and EC 
numbers information for an evidence and its associated genes.  Nomenclature suggestions are also 
listed.
 The feature names are external links to MGAT, or the Multiple Gene Alignment Tool, 
page, allows the annotator to simultaneously annotate related genes in multiple genomes (Figure 
24). Similarly, the locus IDs are links to the gene’s corresponding Gene Curation page, JCVI’s 
manual annotation tool (Figure 25). These links offer JCVI’s curators a more direct means of 
editing gene assignments to correct the individual inconsistencies and inaccuracies found by 
ACT. 
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Figure 24. MGAT Page
Figure 24. Sample Multiple Gene Alignment Tool (MGAT) page.
Figure 25. Gene Curation Page
Figure 25. Sample Gene Curation page.
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In the upper right hand corner of each inconsistent evidence table, are two icons as seen 
in Figure 26. These images allow access to the comment functionality of Web-based ACT. 
The icon, , when clicked, displays the comments for the current evidence. The 
comments are displayed in a simple table as seen in Figure 27 (left image). The first column is 
the username of the commenter, the second column is the timestamp in the format of: date month 
year time. The local time is given in the 24-hour format (ex. 13:57 is 1:57PM). There are three 
values designated as the time: hours:minutes:seconds. The third column is the actual comment 
made. So, in the case of the first  comment listed, the user, ‘abenjamin added a comment on 
evidence ‘TIGR01469’ saying “Another comment has been entered for TIGR01469” on May 8 
of 2009 at the time of 19:27:40. Finally, the fourth column is an indication of the assessment 
status. If the value in this column is “false”, then assessment was not completed during the time 
the comment was made. If the value is “true”, the assessment has been completed. If no 
comments exist for the current evidence, an appropriate message in the format of “No comments 
for [EVIDENCE_ACCESSION]” is displayed. The user is also provided with a link to the Add 
Comment form.
Figure 26. Comments Function Icons
               
Figure 26. Hyperlink icons to read (left image) and write 
(right image) associated comments.
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The icon, , when clicked, displays a form that allows user to add comments on the 
current evidence as seen in Figure 28. Two of the four fields are automatically filled by ACT. 
The auto-filled fields are the evidence ID field and the date, or timestamp, field so as to maintain 
the proper format. The user is required to fill out both the user name field and, of course, the 
comment field. The last field, “Assessment Completed”, indicates to ACT whether or not 
assessment for the specified HMM has been completed. ACT defaults at “no”, but when the user 
specifies “yes” for this field, ACT will treat the specified HMM as having been assessed in future 
ACT runs.
Figure 27. Reading Comments
 
Figure 27. A page displays the comments associated with the current evidence (left image) or, in the case that no 
comments exist, a message is displayed to indicate that there are no comments  for the current evidence (right 
image).
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Figure 28. Adding Comments
 
Figure 28.  The Add Comment form allows users to add comments to the current evidence. An empty form (left 
image) is first displayed. The user then specifies her username and her comment (right image).
 When the ‘Add Comment’ form is submitted by the user, a message is displayed. If the 
comment was successfully saved, a “success” message is displayed on the browser along with a 
link to the ‘Read Comment’ page (Figure 29, left image). However, if the submission was not 
successful because the user did not complete a field, a “failure” message is displayed (Figure 29 
right image). This message indicates “An error has occurred. Please check that all fields have 
been filled. This comment was NOT saved.”
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Figure 29. Add Comments Messages
 
Figure 29.  A success message (left image) is reported when the comment was saved. A failure message (right 
image) is reported when an error has occurred.
ACT Results Analysis
 Analyses on all genomes within the scope of ACT were performed. The analyses were 
divided into three separate runs, one for each of the genome types: microbial genomes, BRC-
microbial genomes, and NT-microbial genomes. The following results were reported.
 In the analysis of the 286 microbial genomes, a total of 139,784 genes were analyzed as 
seen in Figure 30. Of those genes, 46,347 were found to be inconsistent with the evidence used 
as the basis to assign functional annotation to them.
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In the analysis of the 111 BRC-microbial genomes, a total of 85,161 genes were analyzed 
as seen in Figure 31. Of those genes, 29,072 were found to be inconsistent with the evidence 
used as the basis to assign functional annotation to them.
Figure 30. Analysis Results for Microbial Genomes
Figure 30.  Statistical results of the analysis of all microbial genomes as of 16 
April 2009.
Figure 31. Analysis Results for BRC-Microbial Genomes
Figure 31. Statistical results of the analysis of all BRC-microbial genomes as of 
16 April 2009.
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 In the analysis of the 484 NT-microbial genomes, a total of 278,215 genes were analyzed 
as seen in Figure 32. Of those genes, 87,961 were found to be inconsistent with the evidence 
used as the basis to assign functional annotation to them.
Figure 32. Analysis Results for NT-Microbial Genomes
Figure 32.  Statistical results of the analysis of all BRC-microbial genomes.  as of 
16 April 2009.
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Discussion
ACT Evaluation
ACT has undergone a drastic reconstruction all in the name of usability. A simple 
alteration in the SQL queries resulted in approximately a 33% decrease in the average runtime 
per genome from one (1) minute per genome to forty-one (41) seconds per genome. 
Restructuring the algorithm to reduce the number of iterations decreased the average runtime per 
genome to two (2) seconds. That  is an approximate decrease of 95% of the improved runtime 
average (after SQL optimization) and approximately 97% from the original runtime average. 
Implementing a more dynamic interface for Web-based ACT allows for an easier, more 
productive experience. The Web-based interface alone is more structured and organized with the 
incorporation simple CSS. The use of jQuery enabled the incorporation of several new features. 
The user can filter the list of genomes on the ACT Start-up Page form. The user is also able to 
keep  track of those HMMs which have already been assessed with the addition of the Comments 
functionality. This reduces the chance that the user will evaluate the same evidence more than 
necessary  by  keeping record of the assessments made for any single evidence. Also, only  those 
inconsistent evidence information tables which have not yet been viewed and commented on will 
be showed in the expanded form. This reduces the clutter of information shown on the page. 
However, even with these vast improvements to ACT, there remains room for further 
development.
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Future Work
Although an extreme reduction of average genome run-time of one (1) minute per 
genome to an average of two (2) seconds per genome has been achieved, the run-time can be 
decreased further. A further reduction of runtime would allow users to include more genomes in 
analyses performed by Web-based ACT without the browser timing out. If every genome (a total 
of 881 genomes) within ACT’s expanded scope is chosen for analysis by  Web-based ACT, it 
would take, on average, 30 minutes to complete. The default Apache configuration is to time out 
a request after 10 minutes. Thus, without reconfiguring Apache, a maximum of 300 genomes (10 
minutes with 300 genomes at 2 seconds per genome) at any one time can be processed in a 
request.
ACT’s analysis scope is rather limited. As of now, ACT can only analyze one evidence 
type, ‘HMM2’. Even more important, only a portion of the HMMs are being analyzed: equivalog 
HMMs, equivalog domain HMMs, and hypothetical equivalog HMMs. It  would be in the best 
interest of annotators for ACT to allow more evidence types and more HMM  isology types to be 
analyzed. Evidence types of expressed interest include, but are not  limited to, PFAM HMM, 
COG, Interpro, and PROSITE. Other evidence types include BER, BLASTN, AUTO_BER, 
COG accession, RULE_BASE, FPrintScan, BlastProDom, EPI, ProfileScan, ScanPrositeC, 
Interpro, and para. Other TIGRFAM HMM isology types include hypothetical equivalog domain, 
Pfam, Pfam equivalog, Pfam equivalog domain, domain, exception, paralog, paralog domain, 
paralog repeat, repeat, signature, subfamily, subfamily domain, and superfamily. The 
incorporation of more evidence types and isology types would make ACT a more robust tool.
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Currently, nomenclature suggestions are derived from the IUBMB. It  may prove to be 
beneficial to allow for more nomenclature suggestions from other databases. This would provide 
annotators with more nomenclature options to make a more informed decision when assigning 
gene annotations.
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Conclusion
The abundance of available genomic sequences has sparked the need for a faster, more 
efficient means of annotation rather than manual annotation. Manual annotation by  a human 
curator is both time-consuming and costly. Thus, annotation groups, like those at the JCVI, have 
developed pipelines for automated gene annotation. These automated pipelines, however, require 
constant maintenance to ensure acceptable levels accuracy and consistency. As annotation groups 
strive for speedy  genome annotations, assessments and evaluations to ensure the credibility and 
integrity of the annotations become all the more necessary.
While periodical assessments are performed, these evaluations do not identify specific 
areas of concern of an annotation group’s annotation pipeline. The Annotation Consistency Tool 
was developed to do so, and by evaluating ACT’s categorized inconsistency statistics, JCVI’s 
annotation group can more easily recognize the root of the inaccuracies and inconsistencies of 
their automated pipelines and assess those issues in order to maintain higher levels of accuracy 
and consistency. Thus, the Annotation Consistency Tool aids annotation groups in their quest  to 
provide quick but reliable data to the scientific public. Now, with the incorporation of the much-
needed updates and improvements, ACT has taken a step toward more reliable and consistent 
genome annotations.
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